Literature DB >> 3284504

Stimulation of an alpha like DNA polymerase by v-myc related protein of Halobacterium halobium.

K Ben-Mahrez1, W Sougakoff, M Nakayama, M Kohiyama.   

Abstract

Partial DNA sequencing of a genomic clone of the archaebacterium Halobacterium halobium, which hybridized with an avian v-myc probe, showed especially the presence, in the organism of one of the conserved regions through myb, myc and adenovirus E1a oncogenes. The archaebacterial deduced amino acid sequence displayed significant homology with the v-myc gene product. In accordance with the partial DNA sequencing which assured a sufficient homology to have similar epitopes, a protein having a molecular weight of 70,000 and possessing high antigenicity with a polyclonal antiserum against avian v-myc protein was isolated and purified from H. halobium extracts. The purified v-myc like protein stimulated in vitro DNA synthesis carried out by the alpha like DNA polymerase of H. halobium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284504     DOI: 10.1007/bf00422002

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  21 in total

1.  Phylogenetic structure of the prokaryotic domain: the primary kingdoms.

Authors:  C R Woese; G E Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

Review 2.  Archaebacteria and the origin of the eukaryotic cytoplasm.

Authors:  W Zillig; R Schnabel; K O Stetter
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

3.  Participation of c-myc protein in DNA synthesis of human cells.

Authors:  G P Studzinski; Z S Brelvi; S C Feldman; R A Watt
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

4.  Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29.

Authors:  K Alitalo; J M Bishop; D H Smith; E Y Chen; W W Colby; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  Similar amino acid sequences: chance or common ancestry?

Authors:  R F Doolittle
Journal:  Science       Date:  1981-10-09       Impact factor: 47.728

6.  Transformation of Brown Leghorn chicken embryo fibroblasts by avian myeloblastosis virus proviral DNA.

Authors:  J Soret; C Kryceve-Martinerie; J Crochet; B Perbal
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

7.  Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.

Authors:  T Yamamoto; S Ikawa; T Akiyama; K Semba; N Nomura; N Miyajima; T Saito; K Toyoshima
Journal:  Nature       Date:  1986 Jan 16-22       Impact factor: 49.962

8.  Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29.

Authors:  W W Colby; E Y Chen; D H Smith; A D Levinson
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Identification of nuclear proteins encoded by viral and cellular myc oncogenes.

Authors:  K Alitalo; G Ramsay; J M Bishop; S O Pfeifer; W W Colby; A D Levinson
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

View more
  3 in total

1.  Genomic organization of the halophilic archaeon Haloferax mediterranei: physical map of the chromosome.

Authors:  P López-García; J P Abad; C Smith; R Amils
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

2.  Genomic stability in the archaeae Haloferax volcanii and Haloferax mediterranei.

Authors:  P López-García; A St Jean; R Amils; R L Charlebois
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

3.  Detection of circulating antibodies against c-myc protein in cancer patient sera.

Authors:  K Ben-Mahrez; D Thierry; I Sorokine; A Danna-Muller; M Kohiyama
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.